logo-loader
Callitas Health Inc.

Callitas Health promotes Joshua Maurice to sales VP

Maurice’s promotion comes as the clinical-stage pharmaceutical development group advances its programs and partnerships

desk
Callitas Health is developing innovative remedies for weight management, female sexual health, cannabis delivery and other proprietary drugs

Callitas Health Inc (CSE:LILY) (OTCQB:MPHMF) said Tuesday that Joshua Maurice has been promoted to vice-president of sales and business development.

Maurice’s promotion comes as the clinical-stage pharmaceutical development group adds to its management and hires consultants to advance its programs and partnerships and build on this year’s progress.

READ: Callitas Health banks on CannaStrips and OTC products while swinging for the fence with blockbuster drugs

“We’ve seen important strides in the first months of 2019 across the women’s health, cannabinoid and infertility spaces and deepening partnerships with companies like NFI Consumer Healthcare and Lifestyles,” said James Thompson, CEO of Callitas, in a statement.

“Promoting Joshua to this new position allows us to utilize his talents to further capitalize on these advancements in the company,” he added.

Formed in early 2015, Callitas Health is developing innovative remedies for weight management, female sexual health, cannabis delivery technologies and other proprietary drugs.

Callitas shares slipped a cent to hit $0.10 in New York trade on Tuesday morning.

Contact Ellen Kelleher at [email protected]

Quick facts: Callitas Health Inc.

Price: $0.11

Market: CSE
Market Cap: $3.62 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Callitas Health Inc. named herein, including the promotion by the Company of Callitas Health Inc. in any Content on the Site, the Company...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Callitas Therapeutics signs LOI with Simply Wholeistic, updates on THC & CBD...

Callitas Therapeutics (CSE:LILY) (OTCQB:MPHMF) Vice President of Sales & Business Development Joshua Maurice tells Proactive Investors the pharma company has signed a letter of intent with Simply Wholeistic to manufacture  its CannaStrip products in the U.S. Maurice added that as...

on 25/4/19

2 min read